Magyaya, Dareen T.
HRN: 16-04-41 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2022
METRONIDAZOLE 500MG (TAB)
05/14/2022
05/20/2022
PO
500mg
TID
Entamoeba Histolytica Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes